These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9408801)

  • 1. Unmasking the heterogeneity of Alzheimer's disease: case studies of individuals from distinct neuropsychological subgroups.
    Fisher NJ; Rourke BP; Bieliauskas LA; Giordani B; Berent S; Foster NL
    J Clin Exp Neuropsychol; 1997 Oct; 19(5):713-54. PubMed ID: 9408801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological subgroups of patients with Alzheimer's disease: an examination of the first 10 years of CERAD data.
    Fisher NJ; Rourke BP; Bieliauskas LA
    J Clin Exp Neuropsychol; 1999 Aug; 21(4):488-518. PubMed ID: 10550808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verbal fluency patterns in two subgroups of patients with Alzheimer's disease.
    Fisher NJ; Tierney MC; Rourke BP; Szalai JP
    Clin Neuropsychol; 2004 Feb; 18(1):122-31. PubMed ID: 15595364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological subgroups of patients with Alzheimer's disease.
    Fisher NJ; Rourke BP; Bieliauskas L; Giordani B; Berent S; Foster NL
    J Clin Exp Neuropsychol; 1996 Jun; 18(3):349-70. PubMed ID: 8877620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional ability in executive variant Alzheimer's disease and typical Alzheimer's disease.
    Back-Madruga C; Boone KB; Briere J; Cummings J; McPherson S; Fairbanks L; Thompson E
    Clin Neuropsychol; 2002 Aug; 16(3):331-40. PubMed ID: 12607146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study.
    Rosselli MC; Ardila AC; Moreno SC; Standish VC; Arango-Lasprilla JC; Tirado VM; Ossa JM; Goate AM; Kosik KS; Lopera F
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):483-95. PubMed ID: 10923058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological asymmetry in Alzheimer's disease: verbal versus visuoconstructional deficits across stages of dementia.
    Strite D; Massman PJ; Cooke N; Doody RS
    J Int Neuropsychol Soc; 1997 Sep; 3(5):420-7. PubMed ID: 9322400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustering and switching in semantic fluency: predictors of the development of Alzheimer's disease.
    Fagundo AB; López S; Romero M; Guarch J; Marcos T; Salamero M
    Int J Geriatr Psychiatry; 2008 Oct; 23(10):1007-13. PubMed ID: 18416452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering and switching processes in semantic verbal fluency in the course of Alzheimer's disease subjects: results from the PAQUID longitudinal study.
    Raoux N; Amieva H; Le Goff M; Auriacombe S; Carcaillon L; Letenneur L; Dartigues JF
    Cortex; 2008 Oct; 44(9):1188-96. PubMed ID: 18761132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alzheimer's disease and Parkinson's disease: neuropsychological differentiation].
    Lavernhe G; Pollak P; Brenier F; Gaio JM; Hommel M; Pellat J; Perret J
    Rev Neurol (Paris); 1989; 145(1):24-30. PubMed ID: 2646680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial cognition in Alzheimer's disease: subtypes of global-local impairment.
    Delis DC; Massman PJ; Butters N; Salmon DP; Shear PK; Demadura T; Filoteo JV
    J Clin Exp Neuropsychol; 1992 Jul; 14(4):463-77. PubMed ID: 1400912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of spelling breakdown in Alzheimer's disease is independent of disease progression.
    Pestell S; Shanks MF; Warrington J; Venneri A
    J Clin Exp Neuropsychol; 2000 Oct; 22(5):599-612. PubMed ID: 11094395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory for new information as a cognitive marker of liability to Alzheimer's disease in a high risk group: a research note.
    Rice F; Abraham R; Rudrasingham V; Owen MJ; Williams J
    Int J Geriatr Psychiatry; 2003 Feb; 18(2):155-60. PubMed ID: 12571825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.
    Lambon Ralph MA; Patterson K; Graham N; Dawson K; Hodges JR
    Brain; 2003 Nov; 126(Pt 11):2350-62. PubMed ID: 12876147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between neuropsychological performance and daily functioning in individuals with Alzheimer's disease: ecological validity of neuropsychological tests.
    Farias ST; Harrell E; Neumann C; Houtz A
    Arch Clin Neuropsychol; 2003 Aug; 18(6):655-72. PubMed ID: 14591439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological performance in early and late onset Alzheimer's disease: comparisons in a memory clinic population.
    Suribhatla S; Baillon S; Dennis M; Marudkar M; Muhammad S; Munro D; Spreadbury C; Lindesay J
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1140-7. PubMed ID: 15526308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.